−0.85 EUR
−11.30 M EUR
36.96 M EUR
5.16 M
About APONTIS PHARMA AG
Sector
CEO
Bruno Wohlschlegel
Headquarters
Monheim am Rhein
Website
Founded
2018
ISIN
DE000A3CMGM5
FIGI
BBG0107RVJ96
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. Its single pill products focus on cardiovascular diseases such as hypertension, hyperlipidemia, and secondary prevention. The company was founded on March 19, 2018 and is headquartered in Monheim am Rhein, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APPH is 10.10 EUR — it has increased by 1.00% in the past 24 hours. Watch APONTIS PHARMA AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange APONTIS PHARMA AG stocks are traded under the ticker APPH.
APPH stock has risen by 1.81% compared to the previous week, the month change is a 3.91% rise, over the last year APONTIS PHARMA AG has showed a 112.18% increase.
We've gathered analysts' opinions on APONTIS PHARMA AG future price: according to them, APPH price has a max estimate of 16.00 EUR and a min estimate of 10.00 EUR. Watch APPH chart and read a more detailed APONTIS PHARMA AG stock forecast: see what analysts think of APONTIS PHARMA AG and suggest that you do with its stocks.
APPH reached its all-time high on Sep 28, 2021 with the price of 30.16 EUR, and its all-time low was 3.17 EUR and was reached on Nov 9, 2023. View more price dynamics on APPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APPH stock is 1.20% volatile and has beta coefficient of 0.03. Track APONTIS PHARMA AG stock price on the chart and check out the list of the most volatile stocks — is APONTIS PHARMA AG there?
Today APONTIS PHARMA AG has the market capitalization of 84.13 M, it has increased by 0.50% over the last week.
Yes, you can track APONTIS PHARMA AG financials in yearly and quarterly reports right on TradingView.
APPH net income for the last half-year is 702.80 K EUR, while the previous report showed −7.78 M EUR of net income which accounts for 109.03% change. Track more APONTIS PHARMA AG financial stats to get the full picture.
No, APPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APONTIS PHARMA AG EBITDA is −7.61 M EUR, and current EBITDA margin is −36.93%. See more stats in APONTIS PHARMA AG financial statements.
Like other stocks, APPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APONTIS PHARMA AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APONTIS PHARMA AG technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APONTIS PHARMA AG stock shows the buy signal. See more of APONTIS PHARMA AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.